Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy

Magnetic Resonance in Medicine

Volumn 35, Issue 5, 1996, Pages 664-670

  Bottomley, Paul A ^a,b   Atalar, Ergin ^a   Weiss, Robert G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JHOC 4221 ^*  (United States)

Author keywords

Heart; Metabolite; Phosphorus; Quantification

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOMOLECULES; CHROMIUM COMPOUNDS; HEART; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATES; PHOSPHORUS; SULFUR COMPOUNDS; TISSUE;

CARDIAC PATIENTS; HIGH ENERGY PHOSPHATES; HUMAN CALF MUSCLE; METABOLITE CONCENTRATIONS; QUANTIFICATION; QUANTIFICATION METHODS; SENSITIVITY CORRECTIONS; SIGNAL SENSITIVITY;

URANIUM COMPOUNDS;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART DISEASE; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHATE METABOLISM;

EID: 0029864572     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910350507     Document Type: Article

References (29)

1. 31P NMR spectroscopy. Science 229, 769-772 (1985).
2. R. G. Weiss, P. A. Bottomley, C. J. Hardy, G. Gerstenblith, Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N. Engl. J. Med. 323, 1593-1600 (1990).
3. T. Yabe, K. Mitsunami, M. Okada, S. Morikawa, T. Inubushi, M. Kinoshita, Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during hand-grip exercise. Circulation 89, 1709-1716 (1994).
4. 31P magnetic resonance spectroscopy. Lancet 338, 973-976 (1991).
5. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Circulation 86, 1810-1818 (1992).
6. P. A. Bottomley, R. J. Herfkens, L. S. Smith, T. M. Bashore, Altered phosphate metabolism in myocardial infarction: P-31 MR spectroscopy. Radiol 165, 703-707 (1987).
7. 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction. Jap. Circ. J. 56, 614-619 (1992).
8. 31P NMR spectroscopy (abstract), in "Proc., SMRM, 11th Annual Meeting, Berlin, 1992," p. 2305.
9. P. A. Bottomley, MR spectroscopy of the human heart: The status and the challenges. Radiology 191, 593-612 (1994).
10. 31P magnetic resonance spectroscopy. Circulation 92, 15-23 (1995).
11. J. L. Swain, R. L. Sabina, R. B. Peyton, R. N. Jones, A. S. Wechsler, E. W. Holmes, Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc. Natl. Acad. Sci. USA 79, 655-659 (1982).
12. P. A. Bottomley, C. J. Hardy, P B. Roemer, Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn. Reson. Med. 14, 425-434 (1990).
13. P. A. Bottomley, C. J. Hardy, Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin. Chem. 35, 392-395 (1989)
14. 31P NMR spectra for partial saturation. Evidence that saturation factors for PCr/ATP are homogeneous in normal and disease states. J. Magn. Reson. 95, 341-355 (1991).
15. 1. A scheme for analysis of in vivo metabolites. J. Magn. Reson. 55, 357-371 (1983).
16. E. B. Cady, Absolute quantitation of phosphorus metabolites in the cerebral cortex of the newborn human infant and in the fore-arm muscles of young adults using a double-tuned surface coil. J. Magn. Reson. 87, 433-446 (1990).
17. 31P MRS. NMR Biomed. 7, 225-230 (1994).
18. 1 values. Magn. Reson. Med. 32, 137-141 (1994).
19. W. S. Snyder, M. J. Cook, E. S. Nasset, L. R. Karhausen, G. P. Howells, I. H. Tipton, "Report of the Task Group on Reference Man. International Commission on Radiological Protection, No. 23," pp. 280-285, p. 34, p. 116, Pergamon Press, Oxford, 1984.
20. C. J. Hardy, R. G. Weiss, P. A. Bottomley, G. Gerstenblith, Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am. Heart J. 122, 795-801 (1991).
21. A. de Roos, J. Doornbos, P. R. Luyten, L. J. M. P. Oosterwaal, E. E. van der Wall, J. A. den Hollander, Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: Assessment with proton-decoupled P-31 MR spectroscopy. J Magn. Reson Imaging 2, 711-719 (1992).
22. F. A. Oski, A. J. Gottlieb, M. Delivoria-Papadopoulos, W. W. Miller, Red cell 2 3-diphosphoglycerate levels in subjects with chronic hypoxemia. N. Engl. J. Med. 280, 1165-1166 (1969).
23. S. Minakami, C. Suzuki, T. Saito, H. Yoshikawa, Studies on erythrocyte glycolysis I. Determination of the gycolytic intermediates in human erythrocytes. J. Biochem. 58, 543-550 (1965).
24. R. H. T. Edwards, M. J. Dawson, D. R. Wilkie, R. E. Gordon, D. Shaw, Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet i, 725-731 (1982).
25. P. N. Venkatasubramanian, M. F. Mafee, M. Barany, Quantitation of phosphate metabolites in human leg in vivo. Magn. Reson. Med. 6, 359-363 (1988).
26. K. Roth, B. Hubesch, D. J. Meyerhoff, S. Naruse, J. R. Gober, T. J. Lawry, M. D. Boska, G. B. Matson, M. W. Weiner, Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy. J. Magn. Reson. 81, 299-311 (1989).
27. 31P MRS in vivo. Part II: Muscle, liver, kidney. Magn. Reson. Med. 32, 453-458 (1994).
28. D. J. Taylor, P. Styles, P. M. Mathews, D. A. Arnold, D G. Gadian, P. Bore, G. K. Radda, Energetics of human muscle: Exercise-induced ATP depletion. Magn. Reson. Med. 3, 44-54 (1986).
29. R. Balaban, P. Bottomley, T. R. Brown, D. Gadian, C. Mountford, G. K. Radda, B. D. Ross, K. G. Shulman, C. Springer, K. Ugurbil. Advances in Physiological Chemistry by in vivo NMR (meeting report). Magn. Reson. Med. 34, 289-292 (1995).